HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe enteropathy caused by α-heavy chain disease lacking detectable M-proteins.

Abstract
A 57-year-old Japanese man was admitted to our hospital with diarrhea, weight loss and malabsorption. Due to a high serum IgA level, we suspected α-heavy chain disease (α-HCD). However, no monoclonal IgA was detected on protein electrophoresis or immunofixation. Immunohistochemical staining of intestinal biopsy specimens showed proliferation of CD138(+)IgA(+) cells, compatible with a diagnosis of α-HCD. Most α-HCD patients exhibit M-proteins in the serum on electrophoresis or immunoelectrophoresis; however, some patients lack detectable M-proteins, similar to our patient. Therefore, when α-HCD is suspected based on the clinical features, immunohistochemistry is required to make a diagnosis.
AuthorsMiwa Kurimoto, Takashi Sonoki, Yasushi Nakamura, Yasuhide Yamamoto, Yoshimasa Maeda, Kodai Kuriyama, Toshiki Mushino, Hiroki Hosoi, Shogo Murata, Masaya Shimanuki, Kazuo Hatanaka, Nobuyoshi Hanaoka, Jun Kato, Hideki Nakakuma
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 53 Issue 6 Pg. 581-5 ( 2014) ISSN: 1349-7235 [Electronic] Japan
PMID24633028 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin A
  • Myeloma Proteins
  • multiple myeloma M-proteins
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Diarrhea (etiology)
  • Doxorubicin (administration & dosage)
  • Electrophoresis
  • Humans
  • Immunoglobulin A (blood)
  • Immunohistochemistry
  • Immunoproliferative Small Intestinal Disease (diagnosis, drug therapy)
  • Malabsorption Syndromes (etiology)
  • Male
  • Middle Aged
  • Myeloma Proteins (metabolism)
  • Positron-Emission Tomography
  • Prednisone (administration & dosage)
  • Treatment Outcome
  • Vincristine (administration & dosage)
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: